Skip to content
Delayed ~15 min

LQDA LIQUIDIA

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Tue 10 Nov 2026 · before market open

What 16 analyst firms say about LIQUIDIA: their latest ratings, price targets and how far the stock is from them. How it works

44.40 USD−0.09 (−0.20%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+55.1%to the avg target 68.86 USD+24.46 USD
Buy 7 · Hold 3 · Sell 1

11 rated views · 17 analyst/firm records · 16 firms

Latest report15 Oct 2026avg report date 14 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8027
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8025

Recent analyst activity · last 90 days

Our tracked history has 24 reports on LQDA from 13 analyst firms in the last 90 days (16 firms in the past year).

Comparing each firm's latest target with its previous one: 3 raised their price target, 3 lowered it and 5 have their first observed target in the past year.

Ratings, latest available report against the previous one: 2 upgrades and 0 downgrades.

Latest observed target change: HC Wainwright raised its target from $58.00 (set 2 Oct 2026) to $65.00 on 15 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesJason GerberryHold13 Aug 202692.00 USD
BTIGJulian HarrisonBuy14 Oct 202670.00 USD
CitigroupUnnamed analystHold1 Oct 2026—
H.C. WainwrightAndrew S. FeinBuy15 Oct 202665.00 USD
JefferiesAkash TewariBuy1 Oct 202655.00 USD
JefferiesAmy LiBuy1 Oct 2026—
Lifesci CapitalGaurav MainiBuy14 Oct 202659.00 USD
NeedhamSerge BelangerBuy14 Oct 202658.00 USD
OppenheimerUnnamed analyst—5 Jun 202675.00 USD
Piper SandlerUnnamed analyst—24 Jul 2026129.00 USD
Raymond JamesRyan DeschnerBuy8 Oct 202653.00 USD · 1 Oct 2026
RBC Capital MarketsUnnamed analyst—15 Oct 202665.00 USD
StephensUnnamed analyst—24 Jul 2026130.00 USD
WedbushUnnamed analyst—2 Oct 202658.00 USD
Weiss RatingsUnnamed analyst—22 Sep 2026—
Wells FargoBenjamin BurnettHold14 Oct 202633.00 USD
Data feed RESEARCHResearch TeamSell22 Sep 202622.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 05:52 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.